therapeutic vaccine
Showing 1 - 25 of >10,000
Squamous Cell Carcinoma of Head and Neck Trial (0.5 mL Candin®/injection, Placebo: 0.5 mL Intravenous 0.9% NaCl solution
Not yet recruiting
- Squamous Cell Carcinoma of Head and Neck
- 0.5 mL Candin®/injection
- Placebo: 0.5 mL Intravenous 0.9% NaCl solution (Saline)
- (no location specified)
Jul 17, 2023
HIV Vaccine Trial in São Paulo (Alpha-type-1 Polarizing Dendritic Cells (aDC1) unpulsed with HIV peptides, Alpha-type-1
Not yet recruiting
- HIV Vaccine
- Alpha-type-1 Polarizing Dendritic Cells (aDC1) unpulsed with HIV peptides
- +2 more
-
São Paulo, BrazilHospital das Clínicas da Faculdade de Medicina da USP
Mar 14, 2023
Head and Neck Carcinoma, Adult Disease Trial in Villejuif (HPVDC injection level dose 1, injection level dose 1, HPVDC
Recruiting
- Head and Neck Carcinoma
- Adult Disease
- HPVDC injection level dose 1
- +3 more
-
Villejuif, FranceGustave Roussy
Aug 17, 2023
COVID-19, Therapeutic Vaccine, BCG Trial in Campinas (BCG, Placebo)
Active, not recruiting
- COVID-19
- +4 more
- BCG
- Placebo
-
Campinas, SP, BrazilHospital das Clínicas Unicamp
Mar 23, 2022
Solid Tumor, Adult Trial in Beijing (Vaccine)
Not yet recruiting
- Solid Tumor, Adult
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Aug 3, 2023
HSIL of Cervix Trial in Heze (NWRD08)
Recruiting
- HSIL of Cervix
- NWRD08
-
Heze, Shandong, ChinaHeze Municipal Hospital
Jun 6, 2023
Breast Tumors Trial in France (MAG-TN3 + AS15)
Completed
- Breast Neoplasms
- MAG-TN3 + AS15
-
Lyon, France
- +4 more
Mar 21, 2022
Tuberculosis, Pulmonary Trial in New Delhi, Tripura (RUTI®, Placebo)
Recruiting
- Tuberculosis, Pulmonary
- RUTI®
- Placebo
-
New Delhi, India
- +1 more
Mar 24, 2022
CIN3, Cervical Intraepithelial Neoplasia, Cervical Intraepithelial Neoplasia Grade 3 Trial in Groningen (Vvax001 therapeutic
Recruiting
- CIN3
- +3 more
- Vvax001 therapeutic cancer vaccine
-
Groningen, NetherlandsUniversity Medical Center Groningen (UMCG)
Aug 23, 2023
Advanced Ovarian Cancer Trial in Seattle (AST-201, Paclitaxel, Carboplatin)
Not yet recruiting
- Advanced Ovarian Cancer
- AST-201
- +4 more
-
Seattle, WashingtonUniversity of Washington
Mar 20, 2023
Prostate Cancer, Non Small Cell Lung Cancer, Ovarian Cancer Trial in London, Oxford (OVM-200)
Recruiting
- Prostate Cancer
- +2 more
- OVM-200
-
London, United Kingdom
- +2 more
Apr 26, 2022
Tumor Vaccines for Solid Tumors
Recruiting
- Glioma
- Solid Tumor
- tumor vaccine
- +3 more
-
Shanghai, Shanghai, ChinaHuashan Hospital, Fudan University
Oct 22, 2023
Chronic Hepatitis B Trial in Hamburg (HEPLISAV B; TherVacB, TherVacB)
Not yet recruiting
- Chronic Hepatitis B
- HEPLISAV B; TherVacB
- TherVacB
-
Hamburg, GermanyCTC North
Feb 3, 2023
Tuberculosis, Multidrug Resistant Trial in Chernivtsi, Ivano-Frankivs'k, Kharkiv (RUTI® Therapeutic vaccine, Matching RUTI®
Terminated
- Tuberculosis, Multidrug Resistant
- RUTI® Therapeutic vaccine
- Matching RUTI® Placebo
-
Chernivtsi, Ukraine
- +2 more
Jun 30, 2022
Adrenocortical Carcinoma, Pheochromocytoma, Paraganglioma Trial in Worldwide (EO2401)
Recruiting
- Adrenocortical Carcinoma
- +2 more
- EO2401
-
Houston, Texas
- +9 more
Dec 7, 2021
Metastatic Colorectal Cancer Trial run by the National Cancer Institute (NCI) (Retifanlimab, Therapeutic CEA, Brachyury and MUC1
Not yet recruiting
- Metastatic Colorectal Cancer
- Retifanlimab
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Dec 4, 2023
High Risk Non-Muscle Invasive Bladder Urothelial Carcinoma, Stage 0a Bladder Cancer AJCC v8, Stage 0is Bladder Cancer AJCC v8
Not yet recruiting
- High Risk Non-Muscle Invasive Bladder Urothelial Carcinoma
- +3 more
- PD-L1/IDO Peptide Vaccine
- Pembrolizumab
-
Sacramento, CaliforniaUniversity of California Davis Comprehensive Cancer Center
Apr 24, 2023
Human Immunodeficiency Virus Trial in Bangkok (Ad26.Mos.HIV, MVA-Mosaic, Placebo)
Completed
- Human Immunodeficiency Virus
- Ad26.Mos.HIV
- +2 more
-
Bangkok, Thailand(unnamed)
Dec 29, 2021
Prostate Cancer Trial in Oslo (TENDU)
Recruiting
- Prostate Cancer
- TENDU
-
Oslo, NorwayOslo University Hospital, The Norwegian Radium Hospital
Mar 29, 2022
Glioblastoma, Adult Trial in Worldwide (Multiple dose of EO2401)
Recruiting
- Glioblastoma, Adult
- Multiple dose of EO2401
-
Boston, Massachusetts
- +9 more
Dec 7, 2021
Malignant Tumors of Brain Trial in Durham (tetanus toxoid, therapeutic autologous dendritic cells, therapeutic autologous
Active, not recruiting
- Malignant Neoplasms of Brain
- tetanus toxoid
- +2 more
-
Durham, North CarolinaDuke University Medical Center
Aug 16, 2022
Chronic Hepatitis b Trial in Adelaide (Therapeutic hepatitis B vaccine, Commercial Hepatitis B vaccine)
Not yet recruiting
- Chronic Hepatitis b
- Therapeutic hepatitis B vaccine
- Commercial Hepatitis B vaccine
-
Adelaide, South Australia, AustraliaFlinders University
Mar 7, 2022